Thirdly, the observation of nuclear β-catenin in serrated adenomas that arise via BRAF mutations strongly suggests that high Wnt/β-catenin activity is favored at an early stage of serrated tumor progression via mechanisms yet unknown in human CRC. This evidence concerns the gene BRAF and neoplasm.